On heels of Genome Compiler buy, Twist Bioscience raises small round
Twist Bioscience's platform centers around scaling DNA synthesis, building genetic sequences out at a fraction of the price of what they've historically cost.
Scaling DNA synthesis 10,000-fold: Twist Bioscience raises $81M
Twist Bioscience has plans to enter the pharmaceutical industry with its powerful DNA synthesis technology.
presented by
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.